Acute effects of low-dose interferon-α on serum cortisol and plasma interleukin-6

被引:24
|
作者
Cassidy, EM
Manning, D
Byrne, S
Bolger, E
Murray, F
Sharifi, N
Wallace, E
Keogan, M
O'Keane, V
机构
[1] Beaumont Hosp, Royal Coll Surg Ireland, Dept Psychiat, Dublin, Ireland
[2] Beaumont Hosp, Royal Coll Surg Ireland, Dept Gastroenterol, Dublin, Ireland
[3] Beaumont Hosp, Royal Coll Surg Ireland, Dept Endocrinol, Dublin, Ireland
[4] Beaumont Hosp, Royal Coll Surg Ireland, Dept Immunol, Dublin, Ireland
关键词
cytokine; depression; HPA axis; interferon alpha; interleukin-6;
D O I
10.1177/026988110201600307
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Major depression is associated with both hypothalamic-pituitary-adrenal (HPA) axis overactivity and immune system activation. Depression is a common occurrence following interferon (IFN)-alpha treatment. While IFN-alpha is known to stimulate the HPA axis, little is known about the effects of exogenous IFN-alpha in humans on the proinflammatory cytokine interleukin (IL)-6, a marker of immune system activation. This study examined the acute effects of IFN-alpha on cortisol and IL-6 release, and the time course of any changes in these variables. Serum cortisol and plasma IL-6 were assessed in healthy volunteers over an 8-h period following 3 million units subcutaneous IFN-alpha or placebo using a double-blind, placebo-controlled crossover design. IFN-alpha resulted in a significant increase in both cortisol and IL-6. Regular sampling over 8 h did not delineate any sequential effect of the rise in these variables over time. We conclude that IFN-alpha acutely stimulates both the HPA axis and proinflammatory cytokine release. The hypothesis that the effect of IFN-alpha on the HPA axis is indirect and mediated by IL-6 was not supported by this study. Our findings are nonetheless of relevance to the aetiology of depression following IFN-alpha.
引用
收藏
页码:230 / 234
页数:5
相关论文
共 50 条
  • [1] Acute effects of interferon on serum cortisol and plasma interleukin 6
    Manning, DS
    Cassidy, E
    Byrne, S
    O'Keane, V
    Murray, FE
    GASTROENTEROLOGY, 2002, 123 (01) : 77 - 77
  • [2] Serum interleukin-6 and interferon- in patients with leprosy
    Nada, Essam
    El Taieb, Moustafa
    Fayed, Hanan
    Ibrahim, Hasan
    Yasin, Yasmin
    EGYPTIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY, 2018, 38 (02): : 80 - 84
  • [3] Serum interleukin-6 predicts cortisol release in acute stroke patients
    Szczudlik, A
    Dziedzic, T
    Bartus, S
    Slowik, A
    Kieltyka, A
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2004, 27 (01) : 37 - 41
  • [4] Serum interleukin-6 predicts cortisol release in acute stroke patients
    A. Szczudlik
    T. Dziedzic
    S. Bartus
    A. Slowik
    A. Kieltyka
    Journal of Endocrinological Investigation, 2004, 27 : 37 - 41
  • [5] Distinct effects of interleukin-6 and interferon-γ on differentiating human cortical neurons
    Kathuria, Annie
    Lopez-Lengowski, Kara
    Roffman, Joshua L.
    Karmacharya, Rakesh
    BRAIN BEHAVIOR AND IMMUNITY, 2022, 103 : 97 - 108
  • [6] INCREASE IN SERUM INTERLEUKIN-6, PLASMA ACTH AND SERUM CORTISOL-LEVELS AFTER SYSTEMIC INTERFERON-ALPHA ADMINISTRATION
    SHIMIZU, H
    OHTANI, K
    SATO, N
    NAGAMINE, T
    MORI, M
    ENDOCRINE JOURNAL, 1995, 42 (04) : 551 - 556
  • [7] Serum interferon-γ, interleukin-4, and interleukin-6 in infants with adenovirus and respiratory syncytial virus infection
    Oda, Keiko
    Yamamoto, Yukiyo
    PEDIATRICS INTERNATIONAL, 2008, 50 (01) : 92 - 94
  • [8] Maternal serum interleukin-6, interleukin-8, tumor necrosis factor-α and interferon-γ in preterm labor
    Bahar, AM
    Ghalib, HW
    Moosa, RA
    Zaki, ZMS
    Thomas, C
    Nabri, OA
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2003, 82 (06) : 543 - 549
  • [9] Clinical features, serum interleukin-6, and interferon-γ levels of 34 Turkish patients with hepatoportal sclerosis
    Koksal, Aydm Seref
    Koklu, Seyfettin
    Ibis, Mehmet
    Balci, Mustafa
    Cicek, Bahattin
    Sasmaz, Nurgul
    Sahin, Burhan
    DIGESTIVE DISEASES AND SCIENCES, 2007, 52 (12) : 3493 - 3498
  • [10] Clinical Features, Serum Interleukin-6, and Interferon-γ Levels of 34 Turkish Patients With Hepatoportal Sclerosis
    Aydın Şeref Köksal
    Seyfettin Köklü
    Mehmet İbiş
    Mustafa Balcı
    Bahattin Çiçek
    Nurgül Şaşmaz
    Burhan Şahin
    Digestive Diseases and Sciences, 2007, 52 : 3493 - 3498